Goal-directed Analgesia Using ANI During General Anesthesia in Children With Moyamoya Disease

Last updated: January 5, 2023
Sponsor: Seoul National University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Moyamoya Syndrome

Pain

Treatment

N/A

Clinical Study ID

NCT05672212
2211-149-1381
  • Ages < 18
  • All Genders

Study Summary

Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pediatric patients receiving EDAS surgery for Moyamoya disease

Exclusion

Exclusion Criteria:

  • ASA (American society of anesthsiologists classification) 4-5
  • Emergency surgery
  • patients with chronic pain on medication

Study Design

Total Participants: 40
Study Start date:
January 04, 2023
Estimated Completion Date:
January 04, 2025

Connect with a study center

  • Seoul national university hospital

    Seoul,
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.